Anaplastic thyroid carcinoma with humoral hypercalcemia of malignancy (HHM): An autopsy case report

Endocrine Journal

Volumn 51, Issue 3, 2004, Pages 303-310

  Iwai, Hiroshi ^a   Ohno, Yasuhiro ^a   Aoki, Norihiko ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

HHM; Lip PEIT; PTHrP; Thyroid carcinoma

Indexed keywords

ALCOHOL; CALCIUM; GALLIUM 67; IODINATED POPPYSEED OIL; IODINE 123; PAMIDRONIC ACID; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATE; THALLIUM 201;

AGED; AIRWAY OBSTRUCTION; ANAPLASTIC CARCINOMA; ARTICLE; ASPIRATION BIOPSY; AUTOPSY; CANCER CYTODIAGNOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOGRAPHY; FEMALE; HUMAN; HUMORAL HYPERCALCEMIA OF MALIGNANCY; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LUNG TUMOR; SQUAMOUS CELL CARCINOMA; THYROID CANCER; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; TRACHEA;

AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; CARCINOMA; ETHANOL; FATAL OUTCOME; FEMALE; HUMANS; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; IODIZED OIL; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; PARATHYROID HORMONE-RELATED PROTEIN; THYROID GLAND; THYROID NEOPLASMS; WHOLE-BODY COUNTING;

EID: 3242795953     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.51.303     Document Type: Article

References (38)

1. Strewler GJ. Humoral manifestations of malignancy (2002) In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams Textbook of Endocrinology, 10th ed., WB Saunders, Philadelphia, 1834-1856.
2. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism (2002) In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams Textbook of Endocrinology, 10th ed., WB Saunders, Philadelphia, 1303-1371.
3. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall REH, Kemp BE, Suva LJ, Rodda CP, Ebeling PR, Hudson PJ, Zajac JD, Martin TJ (1987) Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 84: 5048-5052.
4. Rankin W, Grill V, Martin TJ (1997) Parathyroid hormone-related protein and hypercalcemia. Cancer 80: 1564-1571.
5. Kitagawa W, Shimizu K, Akasu H, Tanaka S (2003) Endocrine surgery. The ninth report: the latest data on and clinical characteristics of the epidemiology of thyroid carcinoma. J Nippon Med Sch 70: 57-61.
6. Obara T (1998) Anaplastic carcinoma. In: Takami H, Mori M (eds) A treatment manual for thyroid disease. Nankodo, Tokyo, 95-99.
7. Tsutsui K (1999) Thyroid anaplastic carcinoma: chemotherapy. Naibunpitsu Geka (Endocrine Surg) 16: 37-43 (in Japanese).
8. Ain KB, Egorin MJ, DeSimone PA (2000) Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trails (CATCHIT) Group. Thyroid 10: 587-594.
9. Kobayashi T, Asakawa H, Umeshita K, Takeda T, Maruyama H, Matsuzuka F, Monden M (1996) Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck 18: 36-41.
10. Tennvall J, Lundell G, Hallquist A, Wahlberg P, Wallin G, Tibblin S (1994) Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. Swedish Anaplastic Thyroid Cancer Group. Cancer 74: 1348-1354.
11. Schlumberger MJ, Filetti S, Hay ID. Nontoxic goiter and thyroid neoplasia (2002) In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams Textbook of Endocrinology, 10th ed., WB Saunders, Philadelphia, 457-90.
12. Sato S, Fujii Y, Kakiuchi T, Kasono K, Imamura H, Kondo Y, Mano H, Okabe T, Asano S, Takaku F, Tsushima T, Shizume K (1989) Paraneoplastic syndrome of hypercalcemia and leukocytosis caused by squamous carcinoma cells (T3M-1) producing parathyroid hormone-related protein, interleukin 1α, and granulocyte colony-stimulating factor. Cancer Res 49: 4740-4746.
13. Yoshida A, Asaga T, Masuzawa C, Kawahara S (1993) Detection of cytokines in thyroid cancer cell lines by enzyme-linked immunosorbent assay. Naibunpitsu Geka (Endocrine Surg) 10: 9-12 (Abstract in English).
14. Enomoto T, Sugawa H, Inoue D, Miyamoto M, Kosugi S, Takahashi T, Kitamura N, Yamamoto I, Konishi J, Mori T, Imura H (1990) Establishment of a human undifferentiated thyroid cancer cell line producing several growth factors and cytokines. Cancer 65: 1971-1979.
15. Yazawa S, Toshimori H, Nakatsuru K, Katakami H, Takemura J, Matsukura S (1995) Thyroid anaplastic carcinoma producing granulocyte-colony-stimulating factor and parathyroid hormone-related protein. Internal Medicine 34: 584-588.
16. Ito Y, So T, Murayama M, Yasuda K, Miura K, Kitakami H, Matsukura S (1993) Two cases of thyroid papillary carcinoma with hypercalcemia and increased serum parathyroid hormone-related peptide-like immunoreactivity (PTHrP-LI). Horumon to Rinsho 41: 109-114 (in Japanese).
17. Nichols CW Jr, Lindsay S, Sheline GE, Chaikoff IL (1965) Induction of neoplasms in rat thyroid glands by x-irradiation of a single lobe. Arch Path 80: 177-183.
18. Mazzaferri EL (1987) Papillary thyroid carcinoma: factors influencing progress and current therapy. Semin Oncol 14: 315-332.
19. Farid NR, Shi YF, Zou MJ (1994) Molecular basis of thyroid cancer. Endocr Rev 15: 202-232.
20. Nishiyama RH, Dunn EL, Thompson NW (1972) Anaplastic spindle-cell and giant-cell tumors of the thyroid gland. Cancer 30: 113-127.
21. Ito T, Seyama T, Mizuno T, Tsuyama N, Hayashi Y, Dohi K, Namamura N, Akiyama M (1993) Genetic alterations in thyroid tumor progression: association with p53 gene mutations. Jpn J Cancer Res 84: 526-531.
22. Silvestrini R, Benini E, Daidone MG (1993) p53 as an independent prognostic marker in lymph-node negative breast cancer patients. J Natl Cancer Inst 85: 965-970.
23. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JK, Hamilton S, Vogelstein B (1990) p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50: 7717-7722.
24. Reznikoff CA, Kao C, Messing EM, Newton M, Swaminathan S (1993) A molecular genetic model of human bladder carcinogenesis. Sem Cancer Biol 4: 143-152.
25. Ito T, Seyama T, Mizuno T, Tsuyama N, Hayashi T, Hayashi Y, Dohi K, Nakamura N, Akiyama M (1992) Unique association of p53 mutation with undifferentiated but not differentiated carcinomas of the thyroid gland. Cancer Res 52: 1369-1371.
26. Nakamura T, Yana I, Kobayashi T, Shin E, Karakawa K, Fujita S, Miya A, Mori T, Nishisho I, Takai S (1992) p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas. Jpn J Cancer Res 83: 1293-1298.
27. Donghi R, Longoni A, Pilotti S, Michieli P, Delia Porta G, Pierotti MA (1993) Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 91: 1753-1760.
28. Dobashi Y, Sakamoto A, Sugimura H, Mernyei M, Mori M, Oyama T, Machinami R (1993) Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 17: 375-381.
29. Lam KY, Lo CY, Chan KW, Wan KY (2000) Insular and anaplastic carcinoma of the thyroid. A 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 231: 329-338.
30. Moretti F, Nanni S, Pontecorvi A (2000) Molecular pathogenesis of thyroid nodules and cancer. Baillieres Best Pract Res Clin Endocrinol Metab 14: 517-539.
31. Soares P, Cameselle-Teijeiro J, Sobrinho-Simoes M (1994) Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology 24: 205-210.
32. Kiyokawa T, Ohno Y, Iwai H, Harada T, Aoki N (2002) The study of percutaneous ethanol injection therapy (PEIT) for thyroid cyst and Plummer's disease. The examination on ultrasonography. Shinriou to Shinyaku 39: 772-773 (in Japanese).
33. Fukunari N (2002) Percutaneous ethanol injection therapy (PEIT) for thyroid diseases. Shinriou to Shinyaku 39: 767-769 (in Japanese).
34. Akasu H, Shimizu K, Kitagawa W, Naito Z, Kawanami O, Tanaka S (2002) Histological study of papillary thyroid carcinoma treated with percutaneous ethanol injection therapy. Pathol Int 52: 406-409.
35. Takano T, Amino N (2002) Cancer-specific mRNAs in thyroid carcinomas: detection, use, and their implication in thyroid carcinogenesis. Endocr J 49: 97-107.
36. Takano T, Hasegawa Y, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Hayashi N, Nakamori S, Amino N (2002) Quantitative analysis of osteonectin mRNA in thyroid carcinomas. Endocr J 49: 511-516.
37. Jueppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF Jr, Hock J, Potts JT Jr, Kronenberg HM, Segre GV (1991) A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254: 1024-1026.
38. Abou-Samra AB, Uneno S, Jueppner H, Keutmann H, Potts JT Jr, Segre GV, Nussbaum SR (1989) Non-homologous sequences of parathyroid hormone related peptide bind to a common receptor on ROS 17/2.8 cells. Endocrinology 125: 2215-2217.